Abstract
Eighty-two patients with small cell lung cancer (SCLC), 32 with limited disease, were treated with alternating chemotherapy. Eight courses were administered at weekly intervals, and responding patients received radiotherapy to sites of bulk disease. Overall response rate was 76.8%. Overall median survival was 265 days, 408 days in patients with limited disease. The median symptom free period after chemotherapy was completed was 123 days. These results are comparable with those in reports of chemotherapy of longer duration and warrant the further investigation of short duration treatment in this disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Comis R L: Small cell carcinoma of the lung.Cancer Treat Rev 9, 237 (1982).
Slevin M L, Harvey V J, Ponder B A J,et al.: Small-cell lung carcinoma: survival after combination chemotherapy, radiotherapy or symptomatic treatment.Br J dis Chest 77, 381 (1983).
Smyth J F, Fowlie S M, Gregor A, Crompton G K, Busuttil A, Leonard R C F, Grant I W B: The impact of chemotherapy on small cell carcinoma of the bronchus.Quart J Med 61 969 (1986).
Souhami R L, Harper P G, Linch D,et al.: High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus.Cancer Chemother Pharmac 10, 205 (1983).
Osterlind K, Soerrenson S, Hansen H H,et al.: Continuous versus alternating chemotherapy for advanced small cell carcinoma of the lung.Cancer Res 43, 6085 (1983).
Daugaard G, Hansen H H, Rorth M: Phase II study of vindesine, cisplatin and hexamethylmelamine (VCH) in small cell carcinoma of the lung.Cancer Treat Rep 68, 1179 (1984).
Lowenbraun S, Birch R, Buchanan R: Combination chemotherapy in small cell lung carcinoma. A randomised study of two regimens.Cancer 54, 2344 (1984).
Klastersky J: Therapy of small cell lung cancer: anything new?Eur J Cancer clin Oncol 24, 107 (1988).
World Health Authority:WHO Handbook for Reporting the Results of Cancer Treatment. WHO Offset Publication No 48. WHO, Geneva (1979).
Carroll K B, Moussalli H, Brown D, Thatcher N: A comparison between a single agent short course chemotherapy regimen and a quadruple prolonged course regimen for small cell bronchogenic cancer.Br J Dis Chest 77, 171 (1983).
Johnson D H, Einhorn L H, Birch R, Vollmer R, Perez C, Krauss S, Omura G, Greco F A: A randomized comparison of high dose versus conventional dose cyclophosphamide, doxorubicin and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the southeastern cancer study group.J clin Oncol 11, 1731 (1987).
Humblet Y, Symann M, Bosly A, Delaunois L, Francis C, Machiels J, Beauduin M, Doyen C, Weynants P, Longueville J, Prignot J: Late intensification therapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomised study.J clin Oncol 5, 1864 (1987).
Kessinger A, Foley J F, Lemon H M: Therapeutic management of small cell lung cancer.J Am Med Ass 250, 3188 (1983).
Morgan D A L, Gilson D, Fletcher J: Vincristine and etoposide: an effective chemotherapy regimen with reduced toxicity in extensive small cell lung cancer.Eur J Cancer clin Oncol 23, 619 (1987).
Thatcher N, James R D, Steward W P,et al.: Three months treatment with cyclophosphamide, VP16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancer.Cancer 56, 1332 (1985).
Thatcher N, Stout R, Smith D B,et al.: Three months chemotherapy and radiotherapy for small cell lung cancer.Br J Cancer 52, 327 (1985).
Spiro S G, Souhami R L, Ash C M,et al.: Randomised trial of planned versus as required chemotherapy in small cell lung cancer.Lung Cancer 4 (suppl.), A101 (1988).
Geddes D M, Law K S, Spiro S G,et al.: Quality of life in small cell carcinoma of the lung: a comparison of two chemotherapy regimes using daily diary cards.Lung Cancer 4 (suppl.), A182 (1988).
Evans W K, Feld R, Osoba D, Shepherd F A, Dill J, Deboer G: VP16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.Cancer 53, 1461 (1984).
Lopez J A, Mann J, Grapski R T: Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.Cancer Treat Rep 69, 369 (1985).
Goldie J H, Coldman A J: A mathematical model for relating the drug sensitivity of tumours to their spontaneous mutation rate.Cancer Treat Rep 63, 1727 (1979).
Daniels J R, Chak L Y, Sikic B I,et al.: Chemotherapy of small-cell carcinoma of lung: a randomised comparison of alternating and sequential combination chemotherapy programs.J clin Oncol 2, 1192 (1984).
Cantwell B M J, Bozzino J M, Corris P, Harris A L: The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer.Eur J Cancer clin Oncol 24, 123 (1988).
Souhami R L, Geddes D M, Spiro S G,et al.: Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial.Br Med J 288, 1643 (1984).
Perez C A, Einhorn L, Oldham R K,et al.: Randomized trial of radiotherapy to the thorax in limited small cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report.J clin Oncol 2, 1200 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crawford, S.M., Parker, D., Glaser, M.G. et al. Treatment of small cell lung cancer by eight weeks chemotherapy. Med. Oncol. & Tumor Pharmacother. 6, 279–283 (1989). https://doi.org/10.1007/BF02985162
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02985162